Skip to main content
. 2014 Jun 27;2014(6):CD010409. doi: 10.1002/14651858.CD010409.pub2

Basta 2005.

Study characteristics
Patient sampling Prospective study; sampling methods are unclear. This study also included women with endometrial and cervical cancer but data were reported separately
Patient characteristics and setting 39 women with vulval cancer FIGO stage I/II were included; number of groins was not reported. Number of midline/lateral lesions and tumour size was not reported
Median age not reported
Setting: a teaching hospital in Poland; enrolment period not reported
Index tests Tc‐99m and blue dye
Histological methods included standard sections stained with H&E and IHC stains
Target condition and reference standard(s) TC: groin lymph node involvement
RS: complete IFL
Flow and timing A total of 2.5 mCi Tc‐99m was injected peritumourally 14 to 18 hours pre‐operatively. 2 hours later, LSG was done. Blue dye (2 to 4 ml) was injected intra‐operatively 20 to 30 minutes before mapping
SND and IFL were performed during the same operation
 Withdrawals, if any, were not described
Comparative  
Notes Limited details reported; no data per groin (requested 21 June 2013)
Methodological quality
Item Authors' judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear    
Was a case‐control design avoided? Yes    
Did the study avoid inappropriate exclusions? Unclear    
    Unclear Unclear
DOMAIN 2: Index Test Test group
Had the test operator performed 10 or more procedures? Unclear    
    Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition? Yes    
Were the reference standard results interpreted without knowledge of the results of the index tests? Unclear    
    Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference standard? Yes    
Did all patients receive the same reference standard? Yes    
Were all patients included in the analysis? Yes    
Were other imaging tests performed prior to the index test to rule out groin lymph node metastases? Unclear    
    Unclear